Publisher
Springer Science and Business Media LLC
Reference58 articles.
1. Gill, S. S. & Hammock, B. D. Distribution and properties of a mammalian soluble epoxide hydrase. Biochemical pharmacology 29, 389–395 (1980).
2. Yu, Z. et al. Soluble Epoxide Hydrolase Regulates Hydrolysis of Vasoactive Epoxyeicosatrienoic Acids. Circulation Research 87, 992–998 (2000).
3. Hou, H. H. et al. N-terminal domain of soluble epoxide hydrolase negatively regulates the VEGF-mediated activation of endothelial nitric oxide synthase. Cardiovasc Res 93, 120–129 (2012).
4. Imig, J. D., Zhao, X., Capdevila, J. H., Morisseau, C. & Hammock, B. D. Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension. Hypertension 39, 690–694 (2002).
5. Alkayed, N. J. et al. Inhibition of brain P-450 arachidonic acid epoxygenase decreases baseline cerebral blood flow. Am J Physiol 271, H1541–1546 (1996).
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献